Ms. Grainne Quinn - 06 Mar 2023 Form 4 Insider Report for PERRIGO Co plc (PRGO)

Role: EVP, Chief Medical Officer
Signature: /s/ Victor Torres, attorney-in-fact for Ms. Grainne Quinn
Issuer symbol: PRGO
Transactions as of: 06 Mar 2023
Net transactions value: +$40,727
Form type: 4
Filing time: 08 Mar 2023, 15:55:25 UTC
Previous filing: 07 Mar 2023
Next filing: 07 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRGO	Ordinary Shares	Options Exercise	$84,848	+2,250	+17%	$37.71	15,233	07 Mar 2023	Direct	F1
transaction	PRGO	Ordinary Shares	Tax liability	$44,121	-1,170	-7.7%	$37.71	14,063	07 Mar 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRGO	Restricted Stock Units	Options Exercise		-2,250	-33%		4,498	07 Mar 2023	Ordinary Shares	2,250		Direct	F1, F2, F3
transaction	PRGO	Restricted Stock Units	Award		+5,276			5,276	06 Mar 2023	Ordinary Shares	5,276		Direct	F2, F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Vesting of service-based restricted stock units granted on 7 March 2022.
F2	Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.
F3	Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 7 March 2023.
F4	Grant of service-based restricted stock units granted on 6 March 2023.
F5	Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 6 March 2024.